EUROPEAN ONCOLOGY & HAEMATOLOGY – SUPPLEMENT 1 (HAEMATOLOGY) – 2016
SUPPLEMENT – HAEMATOLOGY
Introducing the latest European Oncology & Haematology supplement Advancing Our Clinical Perspectives in Haematology – What is Your Approach? , discussing the identification and management of essential thrombocythaemia. This supplement covers proceedings of the 11th New Horizons in Haematology International Conference, 11 March 2016.
Advancing Our Clinical Perspectives in Haematology – What is Your Approach?
Evolution of Knowledge in Essential Thrombocythaemia Disease Presented by: Gunnar Birgegård Division of Medical Sciences, Haematology, Uppsala University, Uppsala, Sweden Essential thrombocythaemia (ET) is a serious disease with significant morbidity and mortality and can sometimes transform to acute myeloid leukaemia (AML).1–3 ET must be differentiated from other myeloproliferative conditions such as polycythemia vera (PV) and […]
Journal articles and more to your inbox
Get the latest clinical insights from touchONCOLOGYSign me up!